Description: Avecho Biotechnology Limited, a biotechnology company, engages in the development and commercialization of human and animal health related products using its proprietary drug delivery system and Tocopherol Phosphate Mixture in Australia. The company operates through Production and Human Health segments. It also produces and sells TPM and Vital ET products for use in drug delivery and cosmetic formulations. In addition, the company's human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. Further, it develops feed additive products to enhance feed efficiency and the health of livestock animals. The company has a collaboration with Lambert Initiative at the University of Sydney for treatment of osteoarthritis. The company was incorporated in 1992 and is based in Clayton, Australia.
Home Page: avecho.com.au
2A Westall Road
Clayton,
VIC
3168
Australia
Phone:
61 3 9002 5000
Officers
| Name | Title |
|---|---|
| Dr. Paul Gavin BSc (Hons), Ph.D. | Chief Executive Officer |
| Dr. Roksan Libinaki Ph.D. | Chief Operating Officer |
| Ms. Melanie Jaye Leydin B.Bus, C.A. | Company Secretary & CFO |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.2336 |
| Price-to-Sales TTM: | 22.8566 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |